FeesSafety
Pluang+

Ethereum struggles near $1,810 amid $29M ETF outflows, eyeing $1,900 recovery level.

18 Nov 2026, 14:35 WIB
Coinpaper
View Source
Bearish
Ethereum struggles near $1,810 amid $29M ETF outflows, eyeing $1,900 recovery level.

Ethereum's price hovers around $1,810 after a nearly 12% drop over the past week, struggling to reclaim the key $1,900 level following a significant selloff. Institutional investors, led by BlackRock, have withdrawn $29 million from Ethereum ETFs, adding pressure to the market. Despite some corporate accumulation and reduced leverage in futures markets, sustained buying demand remains weak. For a short-term recovery, Ethereum needs to hold above $1,800 and push past $1,850 to target $1,900, while failure to maintain support could lead to further declines toward $1,750 or lower.

Ethereum's recent price drop of nearly 12% frames this market snapshot from Pluang as of Nov 18, 2026 19:32 WIB. For readers following cryptocurrency trends, here is Pluang's market snapshot: out of 50 major cryptocurrencies, 20 rose and 28 fell today. Notable movers include LUNC at Rp0,701 with a 1-day change of -4.28% and a Pluang order activity split of 48% Sell / 52% Buy, ATOM at Rp23.427 with -3.75% change and 44% Sell / 56% Buy order activity, and UNI at Rp95.190 with -2.51% change and 32% Sell / 68% Buy order activity.

More News

Lowe's beats Q3 earnings estimates and raises full-year sales outlook.

Lowe's beats Q3 earnings estimates and raises full-year sales outlook.

Lowe's reported adjusted earnings per share of $3.10, surpassing estimates of $2.88, and revenue of $22.80 billion, beating the $22.40 billion forecast. Comparable sales rose 1.8%, driven by strong online and professional services sales. The company ...

Company Fundamentals
Bullish
50 minutes ago
Major Memphis health system expands Daxor's blood volume testing to new outpatient site with 24-hour results.

Major Memphis health system expands Daxor's blood volume testing to new outpatient site with 24-hour results.

Daxor Corporation announced that a major Memphis health system has expanded its Blood Volume Analysis (BVA) program to an additional hospital outpatient site using Daxor’s ezBVA Lab service. This expansion allows the outpatient clinic to receive bloo...

Market News
Bullish
54 minutes ago
Microsoft shares drop 2.27% after global outages despite Oppenheimer's Outperform rating

Microsoft shares drop 2.27% after global outages despite Oppenheimer's Outperform rating

Microsoft's stock fell 2.27% to $506.24 following global outages affecting its Copilot, Teams, and Outlook services. The outages, attributed to server issues rather than cyberattacks, raised concerns amid broader software sector weakness. Oppenheimer...

Market News
Bearish
1 hour ago
Target posts strongest sales growth in 5 years, raises annual sales growth target to 6%.

Target posts strongest sales growth in 5 years, raises annual sales growth target to 6%.

Target Corporation reported earnings per share of $2.65, beating estimates of $2.08, and revenue of $27.1 billion, surpassing the $26.5 billion forecast. The company achieved its strongest quarterly sales growth in about five years, with net sales up...

Company Fundamentals
Bullish
1 hour ago
Aquestive Therapeutics to present at Piper Sandler Healthcare Conference on Dec 2, 2026

Aquestive Therapeutics to present at Piper Sandler Healthcare Conference on Dec 2, 2026

Aquestive Therapeutics announced its participation in the Piper Sandler 38th Annual Healthcare Conference from December 1-3, 2026, in New York City. CEO Daniel Barber will present on December 2 at 10:30 am ET, with one-on-one investor meetings schedu...

Market News
Neutral
1 hour ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App